Literature DB >> 10837473

Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155.

X M Zhou1, Y Liu, G Payne, R J Lutz, T Chittenden.   

Abstract

The Bcl-2 family protein BAD promotes apoptosis by binding through its BH3 domain to Bcl-x(L) and related cell death suppressors. When BAD is phosphorylated on either Ser(112) or Ser(136), it forms a complex with 14-3-3 in the cytosol and no longer interacts with Bcl-x(L) at the mitochondria. Here we show that phosphorylation of a distinct site Ser(155), which is at the center of the BAD BH3 domain, directly suppressed the pro-apoptotic function of BAD by eliminating its affinity for Bcl-x(L). Protein kinase A functioned as a BAD Ser(155) kinase both in vitro and in cells. BAD Ser(155) was found to be a major site of phosphorylation induced following stimulation by growth factors and prevented by protein kinase A inhibitors but not by inhibitors of the phosphatidylinositol 3-kinase/Akt pathway. Growth factors inhibited BAD-induced apoptosis in both a Ser(112)/Ser(136)- and a Ser(155)-dependent fashion. Thus, growth factors engage an anti-apoptotic signaling pathway that inactivates BAD by direct modification of its BH3 cell death effector domain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837473     DOI: 10.1074/jbc.M002526200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins.

Authors:  J Munger; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Calcineurin-mediated Bad translocation regulates cyanide-induced neuronal apoptosis.

Authors:  Yan Shou; Li Li; Krishnan Prabhakaran; Joseph L Borowitz; Gary E Isom
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

3.  Herpes simplex virus protein kinase US3 activates and functionally overlaps protein kinase A to block apoptosis.

Authors:  Luca Benetti; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

Review 4.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

5.  Protection from rapamycin-induced apoptosis by insulin-like growth factor-I is partially dependent on protein kinase C signaling.

Authors:  Kuntebommanahalli N Thimmaiah; John B Easton; Peter J Houghton
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

6.  Survival of HER2-Positive Breast Cancer Cells: Receptor Signaling to Apoptotic Control Centers.

Authors:  Marc Y Fink; Jerry E Chipuk
Journal:  Genes Cancer       Date:  2013-05

7.  Analyses of PDE-regulated phosphoproteomes reveal unique and specific cAMP-signaling modules in T cells.

Authors:  Michael-Claude G Beltejar; Ho-Tak Lau; Martin G Golkowski; Shao-En Ong; Joseph A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-20       Impact factor: 11.205

8.  Determination of protein phosphorylation by polyacrylamide gel electrophoresis.

Authors:  Chang-Ro Lee; Young-Ha Park; Huitae Min; Yeon-Ran Kim; Yeong-Jae Seok
Journal:  J Microbiol       Date:  2019-01-31       Impact factor: 3.422

9.  An extranuclear locus of cAMP-dependent protein kinase action is necessary and sufficient for promotion of spiral ganglion neuronal survival by cAMP.

Authors:  Jinwoong Bok; Xiang-Ming Zha; Yang-Sun Cho; Steven H Green
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

10.  Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation.

Authors:  Rodrigo R Resende; Avishek Adhikari
Journal:  Cell Commun Signal       Date:  2009-08-27       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.